Cite
Turchin I, Bano S, Kirillin M, et al. Combined Fluorescence and Optoacoustic Imaging for Monitoring Treatments against CT26 Tumors with Photoactivatable Liposomes. Cancers (Basel). 2021;14(1)doi: 10.3390/cancers14010197.
Turchin, I., Bano, S., Kirillin, M., Orlova, A., Perekatova, V., Plekhanov, V., Sergeeva, E., Kurakina, D., Khilov, A., Kurnikov, A., Subochev, P., Shirmanova, M., Komarova, A., Yuzhakova, D., Gavrina, A., Mallidi, S., & Hasan, T. (2021). Combined Fluorescence and Optoacoustic Imaging for Monitoring Treatments against CT26 Tumors with Photoactivatable Liposomes. Cancers, 14(1), . https://doi.org/10.3390/cancers14010197
Turchin, Ilya, et al. "Combined Fluorescence and Optoacoustic Imaging for Monitoring Treatments against CT26 Tumors with Photoactivatable Liposomes." Cancers vol. 14,1 (2021). doi: https://doi.org/10.3390/cancers14010197
Turchin I, Bano S, Kirillin M, Orlova A, Perekatova V, Plekhanov V, Sergeeva E, Kurakina D, Khilov A, Kurnikov A, Subochev P, Shirmanova M, Komarova A, Yuzhakova D, Gavrina A, Mallidi S, Hasan T. Combined Fluorescence and Optoacoustic Imaging for Monitoring Treatments against CT26 Tumors with Photoactivatable Liposomes. Cancers (Basel). 2021 Dec 31;14(1). doi: 10.3390/cancers14010197. PMID: 35008362; PMCID: PMC8750546.
Copy
Download .nbib